BlackRock Advisors’s CASI Pharmaceuticals CASI Stock Holding History

BlackRock Advisors’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9K	Hold	774	–	–	﹤0.01%	3576
2016 Q3	$9K	Hold	774	–	–	﹤0.01%	3586
2016 Q2	$9K	Hold	774	–	–	﹤0.01%	3592
2016 Q1	$8K	Hold	774	–	–	﹤0.01%	3605
2015 Q4	$7K	Hold	774	–	–	﹤0.01%	3675
2015 Q3	$8K	Hold	774	–	–	﹤0.01%	3678
2015 Q2	$14K	Hold	774	–	–	﹤0.01%	3571
2015 Q1	$11K	Hold	774	–	–	﹤0.01%	3527
2014 Q4	$10K	Hold	774	–	–	﹤0.01%	3603
2014 Q3	$14K	Buy	+774	New	+$13.8K	﹤0.01%	3551
2014 Q2	–	Sell	-774	Closed	-$14K	–	3671
2014 Q1	$14K	Hold	774	–	–	﹤0.01%	3485
2013 Q4	$13K	Buy	774 +196	+34%	+$3.31K	﹤0.01%	3476
2013 Q3	$10K	Hold	578	–	–	﹤0.01%	3457
2013 Q2	$12K	Buy	+578	New	+$11.2K	﹤0.01%	3366

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

WSC

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Advisors's CASI Position: Q4 2016 in Review

BlackRock Advisors held its CASI Pharmaceuticals (CASI) position steady in Q4 2016 at 774 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3576.

BlackRock Advisors first reported a position in CASI in Q2 2013 and has held it in 14 quarters since. The position peaked at $14K in Q2 2015. 28 funds tracked by Wall St. Rank hold CASI as of Q4 2016.

BlackRock Advisors held 774 shares of CASI Pharmaceuticals worth $9K as of Q4 2016.
BlackRock Advisors left its CASI Pharmaceuticals share count unchanged in Q4 2016.
CASI Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3576 holding.
BlackRock Advisors first reported a position in CASI Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
BlackRock Advisors's CASI Pharmaceuticals position peaked at $14K in Q2 2015.
28 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.